Home
About Us
Overview
Vision, Mission & Core Values
History
Founders
Key Promoters & Directors
Management Team
Corporate Governance
Our Recognition
Products
Pharmaceuticals
By Brand Name
By Generic Name
By Therapeutics Class
Herbal & Nutraceuticals
By Brand Name
By Generic Name
Ayurvedic
By Brand Name
By Generic Name
Veterinary
By Brand Name
By Generic Name
By Therapeutics Class
Facilities
Overview
R&D
General Unit
Cephalosporin Unit
BFS, Liquid & Semi-Solid Unit
Solid Dosage Unit
Penicillin Unit
Hormone & Steroid Unit
Herbal & Ayurvedic Unit
Veterinary Unit
Gallery
Photo Gallery
Virtual Tours
CSR
Overview
Commitment to the Employee
Commitment to the Society
Commitment to Environment
Triple Bottom Line (TBL) Reporting
Mass Extinction Crisis
Business Operations
Marketing, Sales & Distribution
Finance and Accounts
Global Presence
HR & Administration
Corporate Affairs
Information Technology
Legal,Regulatory & QMS
Internal Audit
Investors Corner
Corporate Brief
Director's Report
Financial Reports
Price Sensitive Information
Material Information
Unclaimed Dividend Information
Shareholding Position
Declaration
C G Compliance Status
Code of Conduct
The Principles of Disclosure of MI & PSI
Dividend Distribution Policy
Annual General Meeting
Use of IPO Proceeds
Share Information
Investor Relations Contact
Doctors Corner
Doctors Corner
Customer Feedback
Career
Newsroom/Media
Climate & Environment
Contact Us
Home
About Us
Overview
Vision, Mission & Core Values
History
Founders
Key Promoters & Directors
Management Team
Corporate Governance
Our Recognition
Products
Pharmaceuticals
By Brand Name
By Generic Name
By Therapeutics Class
Herbal & Nutraceuticals
By Brand Name
By Generic Name
Ayurvedic
By Brand Name
By Generic Name
Veterinary
By Brand Name
By Generic Name
By Therapeutics Class
Facilities
Overview
R&D
Quality Operations
General Unit
Cephalosporin Unit
BFS, Liquid & Semi-Solid Unit
Solid Dosage Unit
Penicillin Unit
Hormone & Steroid Unit
Herbal & Ayurvedic Unit
Veterinary Unit
Gallery
Photo Gallery
Virtual Tours
CSR
Overview
Commitment to the Employee
Commitment to the Society
Commitment to Environment
Triple Bottom Line (TBL) Reporting
Mass Extinction Crisis
Business Operations
Marketing, Sales & Distribution
Finance and Accounts
Global Presence
HR & Administration
Corporate Affairs
Information Technology
Legal,Regulatory & QMS
Internal Audit
Investors Corner
Corporate Brief
Director's Report
Financial Reports
Price Sensitive Information
Material Information
Unclaimed Dividend Information
Shareholding Position
Declaration
C G Compliance Status
Code of Conduct
The Principles of Disclosure of MI & PSI
Dividend Distribution Policy
Annual General Meeting
Use of IPO Proceeds
Share Information
Investor Relations Contact
Doctors Corner
Doctors Corner
Customer Feedback
Career
Newsroom/Media
Climate & Environment
Contact Us
Use of IPO Proceeds
2022
2021
2020
2019
2018
2017
2016
Use of IPO Proceeds January-2022
Read More
USE OF IPO PROCEEDS DECEMBER-2021
Read More
Use of IPO Proceeds November-2021
Read More
Use of IPO Proceeds October-2021
Read More
Use of IPO Proceeds September-2021
Read More
Use of IPO Proceeds August-2021
Read More
Use of IPO Proceeds July-2021
Read More
Use of IPO Proceeds June-2021
Read More
Use of IPO Proceeds May-2021
Read More
Use of IPO Proceeds April-2021
Read More
Use of IPO Proceeds March-2021
Read More
Use of IPO Proceeds February-2021
Read More
Use of IPO Proceeds January-2021
Read More
Use of IPO Proceeds December-2020
Read More
Use of IPO Proceeds November-2020
Read More
Use of IPO Proceeds October-2020
Read More
Use of IPO Proceeds September-2020
Read More
Use of IPO Proceeds August-2020
Read More
Use of IPO Proceeds July-2020
Read More
Use of IPO Proceeds June-2020
Read More
Use of IPO Proceeds May-2020
Read More
Use of IPO Proceeds April-2020
Read More
Use of IPO Proceeds March-2020
Read More
Use of IPO Proceeds February-2020
Read More
Use of IPO Proceeds January-2020
Read More
Use of IPO Proceeds December-2019
Read More
Use of IPO Proceeds November-2019
Read More
Use of IPO Proceeds October-2019
Read More
Use of IPO Proceeds September-2019
Read More
Use of IPO Proceeds August-2019
Read More
Use of IPO Proceeds July-2019
Read More
Use of IPO Proceeds June-2019
Read More
Use of IPO Proceeds May-2019
Read More
Use of IPO Proceeds April-2019
Read More
Use of IPO Proceeds March-2019
Read More
Use of IPO Proceeds February-2019
Read More
Use of IPO Proceeds January-2019
Read More
Use of IPO Proceeds December-2018
Read More
Use of IPO Proceeds November-2018
Read More
Use of IPO Proceeds October-2018
Read More
Use of IPO Proceeds September-2018
Read More
Use of IPO Proceeds August-2018
Read More
Use of IPO Proceeds July-2018
Read More
Use of IPO Proceeds June-2018
Read More
Use of IPO Proceeds May-2018
Read More
Use of IPO Proceeds April-2018
Read More
Use of IPO Proceeds March-2018
Read More
Use of IPO Proceeds February-2018
Read More
Use of IPO Proceeds January-2018
Read More
Use of IPO Proceeds December-2017
Read More
Use of IPO Proceeds November-2017
Read More
Use of IPO Proceeds October-2017
Read More
Use of IPO Proceeds September-2017
Read More
Use of IPO Proceeds August-2017
Read More
Use of IPO Proceeds July-2017
Read More
Use of IPO Proceeds June-2017
Read More
Use of IPO Proceeds May-2017
Read More
Use of IPO Proceeds April-2017
Read More
Use of IPO Proceeds March-2017
Read More
Use of IPO Proceeds February-2017
Read More
Use of IPO Proceeds January-2017
Read More
Use-Of-IPO-Proceeds December-2016
Read More
Use Of IPO Proceeds November-2016
Read More
Use Of IPO Proceeds October-2016
Read More
Use Of IPO Proceeds September-2016
Read More
Use Of IPO Proceeds August-2016
Read More
Use Of IPO Proceeds July-2016
Read More
Use Of IPO Proceeds June-2016
Read More
